down arrow

Shanghai Rightongene Biotechnology Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005212
CNY
26.83
-0.11 (-0.41%)

Dec 05

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Shanghai Rightongene Biotechnology Co., Ltd.
Why is Shanghai Rightongene Biotechnology Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 2.56%
  • The company has been able to generate a Return on Capital Employed (avg) of 2.56% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -13.75% and Operating profit at -215.08% over the last 5 years
3
With a fall in Net Sales of -8.97%, the company declared Very Negative results in Mar 25
  • The company has declared negative results for the last 8 consecutive quarters
  • NET PROFIT(9M) At CNY -23.13 MM has Grown at -5,352.93%
  • INTEREST(9M) At CNY 1.07 MM has Grown at inf%
  • NET SALES(9M) At CNY 160.43 MM has Grown at -16.88%
4
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 21.90%, its profits have fallen by -3421%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai Rightongene Biotechnology Co., Ltd. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Shanghai Rightongene Biotechnology Co., Ltd.
22.46%
0.53
42.14%
China Shanghai Composite
15.19%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-13.75%
EBIT Growth (5y)
-215.08%
EBIT to Interest (avg)
5.90
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.30
Tax Ratio
8.57%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.56%
ROE (avg)
2.44%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.09
EV to EBIT
-18.55
EV to EBITDA
-784.96
EV to Capital Employed
1.12
EV to Sales
3.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-6.01%
ROE (Latest)
-3.70%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
PRE-TAX PROFIT(Q)

At CNY 1.73 MM has Grown at 123.53%

NET PROFIT(Q)

At CNY 3.3 MM has Grown at 179.34%

RAW MATERIAL COST(Y)

Fallen by -7.74% (YoY

-20What is not working for the Company
NET PROFIT(9M)

At CNY -23.13 MM has Grown at -5,352.93%

INTEREST(9M)

At CNY 1.07 MM has Grown at inf%

NET SALES(9M)

At CNY 160.43 MM has Grown at -16.88%

ROCE(HY)

Lowest at -1.4%

Here's what is working for Shanghai Rightongene Biotechnology Co., Ltd.
Pre-Tax Profit
At CNY 1.73 MM has Grown at 123.53%
over average net sales of the previous four periods of CNY -7.34 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 3.3 MM has Grown at 179.34%
over average net sales of the previous four periods of CNY -4.16 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CNY MM)

Raw Material Cost
Fallen by -7.74% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shanghai Rightongene Biotechnology Co., Ltd.
Interest
At CNY 1.07 MM has Grown at inf%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales
At CNY 53.99 MM has Fallen at -10.02%
over average net sales of the previous four periods of CNY 60.01 MM
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."